
Muscle Fitness Linked to Bone Health in Youths With T1D
Higher muscular fitness, measured through handgrip strength and muscle power, was strongly associated with higher bone mineral content and areal bone mineral density across multiple skeletal regions in children and adolescents with type 1 diabetes (T1D).
METHODOLOGY:
Young patients with T1D exhibit compromised bone strength, demonstrated by reduced areal bone mineral density and bone mineral content, leading to an elevated lifetime risk for fractures.
Researchers in Spain conducted a longitudinal cohort study to examine the association between muscular fitness and bone mineral content and areal bone mineral density outcomes in children and adolescents with T1D.
They included 83 participants (mean age, 13.7 years; 55% boys; mean diabetes duration, 5.8 years) who had been diagnosed with T1D for more than 6 months; participants were followed up for 2 years, with evaluations conducted annually.
Muscular fitness parameters assessed were handgrip strength, one-repetition maximum strength, and muscle power, measured using a digital dynamometer and other methods.
Outcomes of interest were bone mineral content and areal bone mineral density, assessed using dual-energy x-ray absorptiometry whole-body scans across multiple body regions (total body less head, arms, legs, pelvis, and spine).
TAKEAWAY:
Significant positive longitudinal associations were observed between muscular fitness parameters and bone mineral content for the total body less head (beta coefficient, 16.713, 19.535, and 28.179 for handgrip strength, repetition maximum strength, and muscle power, respectively; P <.05 for all); the associations persisted for other regions of the body as well.
<.05 for all); the associations persisted for other regions of the body as well. Significant associations were also found between muscular fitness parameters and areal bone mineral density for all body regions.
When standardised reference data from the general population were used, youths who had higher z scores of handgrip strength showed higher z scores of bone mineral content (beta coefficient, 0.194; 95% CI, 0.088-0.300) and areal bone mineral density (beta coefficient, 0.350; 95% CI, 0.210-0.490) in the total body less head region.
IN PRACTICE:
"The findings support current clinical guidelines recommending regular monitoring of bone health in youth with type 1 diabetes via DXA [dual-energy x-ray absorptiometry]. They also reinforce existing recommendations advocating at least three days per week of muscle-strengthening activities, as a critical component of care for this population," the authors wrote.
SOURCE:
This study was led by Jacinto Muñoz-Pardeza, Navarrabiomed, Hospital Universitario de Navarra, Universidad Pública de Navarra, IdiSNA, Pamplona, Spain. It was published online on June 05, 2025, in The Journal of Clinical Endocrinology & Metabolism .
LIMITATIONS:
Dual-energy x-ray absorptiometry scans were used to monitor bone mineral content and areal bone mineral density, which limited the measurement of geometric or microarchitectural properties. The analysis was limited to whole-body scans and excluded the hip and lumbar spine regions. Lean mass was not included as a covariate because of multicollinearity with BMI. Moreover, the analyses did not account for participants' fracture histories, which may have confounded the associations.
DISCLOSURES:
This study was supported by grants from the Instituto de Salud Carlos III - ERDF. One author was granted fellowship from the funding institute of this study. Other authors reported having no conflicts of interest.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
4 hours ago
- Medscape
Fast Five Quiz: Ovarian Cancer Overview
Ovarian cancer poses a significant threat to women's health, often developing quietly and without early symptoms. It is commonly discovered after progression. This late detection, along with resistance to treatment and frequent relapse, contributes to poor outcomes. Although medical and surgical interventions have evolved, survival rates remain low. These challenges highlight the critical importance of early detection methods, precise diagnostic technologies, and individualized care coordinated across medical specialties. How much do you know about ovarian cancer? Test your knowledge with this quick quiz. High-grade serous carcinoma is by far the most prevalent, representing approximately 70%-80% of epithelial ovarian cancer cases. In contrast, the low-grade form of serous carcinoma is much less common (< 5%). Endometrioid and clear cell subtypes are each responsible for about 10% of cases and have known associations with endometriosis. Mucinous carcinomas are uncommon, comprising a small fraction (around 3%) of epithelial ovarian cancers. Learn more about ovarian cancer. According to the National Institute for Health and Care Excellence guidelines, for patients with inherited mutations linked to a higher chance of developing ovarian cancer (eg, alterations in BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 ), the most effective preventive surgical procedure is the bilateral salpingo-oophorectomy (which is the removal of both fallopian tubes and ovaries). This intervention has been proven to greatly reduce ovarian cancer risk and enhance long-term survival among these high-risk groups. However, when performed in premenopausal women, it induces menopause. Removing one ovary (unilateral oophorectomy) or the uterus (total hysterectomy) does not offer adequate protection against ovarian cancer. Procedures like cervical conization are unrelated to ovarian cancer and are used to manage cervical abnormalities. Learn more about salpingo-oophorectomy. HRT is typically recommended for women who undergo bilateral salpingo-oophorectomy before reaching the natural age of menopause and have not had breast cancer. This type of surgery causes a sudden and early drop in estrogen levels, which can result in bothersome symptoms and increase the risk for long-term health issues such as bone loss or cardiovascular problems. HRT helps ease these effects and maintain health until the typical menopausal age. In contrast, women older than age 50 years are often already in or near menopause, and HRT is not routinely needed unless specific symptoms arise. Patients who have a history of breast cancer must be assessed on a case-by-case basis because HRT might not be safe. Women with a uterus should be offered combined HRT, whereas women without a uterus should be offered estrogen-only HRT. Additionally, women who have not had their ovaries removed do not experience the abrupt hormonal shift that warrants preventive HRT. Learn more about HRT. Individuals who carry a BRCA1 mutation face a significantly elevated risk of developing ovarian cancer, often at a younger age than those with other hereditary mutations. If a woman with a BRCA1 mutation decides not to undergo surgery to remove her ovaries and fallopian tubes, monitoring for early signs of cancer should begin after age 35 years. This timing aligns with evidence suggesting that BRCA1 -related ovarian cancers tend to occur earlier than those linked to BRCA2 or other genetic variants. Initiating surveillance at age 30 years is generally premature and not part of standard recommendations. For BRCA2 carriers, screening is usually deferred until after age 40 years, whereas those with alterations in genes like RAD51C, RAD51D, BRIP1 , or PALB2 typically begin surveillance after age 45 years. Individuals with Lynch syndrome-related mutations (eg, MLH1, MSH2, MSH6 ) are also advised to start at age 35 years if surgery is postponed. Learn more about breast cancer risk factors. Although mucinous tumors can arise directly from the ovary, many are actually secondary cancers that have spread from other organs, most notably the gastrointestinal system, including the colon and appendix. Distinguishing between primary and metastatic mucinous tumors is crucial for proper diagnosis and management. High-grade serous cancers more commonly begin in the epithelium of the fallopian tubes rather than the ovaries. On the other hand, low-grade serous carcinomas are thought to originate in the ovary and are typically diagnosed in younger females, with outcomes generally more favorable than their high-grade counterparts. Germ cell tumors and sex cord-stromal tumors are far more frequent in adolescents and young adults, with most cases occurring before age 30 years and not in women older than 45. Learn more about endometrioid carcinoma.


Medscape
8 hours ago
- Medscape
Fast Five Quiz: Obstructive HCM Management
Learn more about beta-blockers for obstructive HCM. Guidelines from the US, Canada, and Europe recommend alcohol septal ablation over invasive surgery for patients with advanced age and comorbidities, due to its less invasive nature and shorter recovery time. However, alcohol septal ablation has been associated with higher risk for complete heart block requiring permanent pacing and might result in less uniform reduction in LVOT gradient, similar to myectomy. It should not be used in pediatric or younger patients or those with cardiac abnormalities that would require surgery. Learn more about alcohol septal ablation for obstructive HCM. Transaortic septal myectomy is the preferred treatment for patients with obstructive HCM who have severe, drug-refractory symptoms, according to a state-of-the-art review from the Journal of American College of Cardiology. Similarly, Canadian guidelines note that surgical myectomy is 'usually' the most effective therapy for obstruction and has a low risk for adverse outcomes, although contraindications to its use do exist. The AHA also notes that transaortic septal myectomy adds little risk to other cardiac procedures and that the relief in left ventricular outflow tract obstruction can minimize postoperative hemodynamic instability. Although dual chamber pacing and mitral valve replacement are effective treatments and can be used for management in some cases, transaortic septal myectomy is generally the preferred option. Learn more about surgical myectomy for obstructive HCM. Surgical myectomy is encouraged to be performed in high-volume HCM centers because in-hospital mortality for surgical myectomy is inversely correlated with surgical volume. Specifically, one recent review found that high-volume hospitals had an in-hospital mortality rate for surgical myectomy of 2.4% compared with 3.9% for medium volume and 5.7% for low volume centers. Another recent review notes that mortality rate for surgical myectomy has decreased 'strikingly' from the highs of up to 8% from 30 years ago but also acknowledges the need for more experienced surgeons in the US and Europe to increase its accessibility. Learn more about surgical outcomes for obstructive HCM. A recent review of HCM published by the American Journal of Cardiology lists history of sustained or repetitive ventricular tachycardia, unexplained syncope, massive left ventricular hypertrophy, or extensive late gadolinium enhancement or a family history of this complication as indications for implantable cardioverter-defibrillators. Similarly, the AHA/ACC joint guidelines specifically recommend an implantable cardioverter-defibrillator for patients with any prior history of sudden cardiac arrest, ventricular fibrillation, or sustained ventricular tachycardia. It should also be considered in shared decision-making with a 5-year risk estimate if a patient has an ejection fraction < 50%, apical aneurysm, unexplained syncope, massive left ventricular hypertrophy, or a family history of sudden cardiac death. Though mild left ventricular hypertrophy and minimal late gadolinium enhancement on cardiac MRI can cause cardiovascular events in patients with obstructive HCM, they are typically not sole indicators for implanting a cardioverter-defibrillator. Asymptomatic status with normal exercise capacity is not an indicator as well. Learn more about implantable cardioverter defibrillators for obstructive HCM. This article was created using several editorial tools, including generative AI models, as part of the process. Human review and editing of this content were performed prior to publication. Lead image: Science Source


Geek Vibes Nation
9 hours ago
- Geek Vibes Nation
'Operation Crossbow' Blu-Ray Review - A Thrilling Wartime Espionage Tale
A fearsome rumor reaches Britain's World War II command. The Nazis are developing rocket technology that could rain death on London and then New York. Quickly, England develops a plan to send saboteurs into the sites manufacturing the rockets. Just moments after the carefully chosen commandos parachute into the drop zone, their pilot receives an urgent message: The mission may be compromised. Abort. Operation Crossbow is the partly fact-based tale of how that team succeeded against daunting odds. Michael Anderson (The Dam Busters, Logan's Run) directs, guiding a huge cast in a film that builds to a spectacular finale, yet never neglects war's unsparing personal costs. As a record of a wartime espionage incursion and as an intrigue-filled thriller, Operation Crossbow is on both counts Operation Accomplished. For thoughts on Operation Crossbow, please check out my thoughts on No Streaming Required: Video Quality Warner Archive presents Operation Crossbow with a sterling 1080p master transfer released in 2019 in its original 2.35:1 aspect ratio sourced from a 2K scan of the Interpositive that looks like a dream. Viewers are unlikely to spot the difference between this and a scan from the Original Camera Negative, given the amazing effort from the label. The film exhibits no serious signs of wear and tear or debris. Even momentary softness during optical transitions that cannot be avoided is handled with care. The colors of the environments are striking with memorable touches in the clothing and production design. Each hue is ideally saturated for first-rate accuracy. Black levels are deep with impeccable stability throughout, and highlights similarly hold firm. Detail and clarity are of the highest order with the sumptuous natural film grain intact and resolved consistently. There are no unwanted digital fumbles such as compression artifacts, banding, or any other such issues. Warner Archive showed off with this one. Audio Quality The Blu-Ray comes with a DTS-HD 5.1 Master Audio track that comes to life quite memorably. There is quite a bit of chatter at the base in German with English subtitles, and the overwhelmingly English dialogue sounds great, as well. Things kick into gear in your speakers as you fully engage with the thrilling finale. The score from Ron Goodwin is used perfectly to transport you into this spy thriller filled with simmering emotions. Even when it is particularly active, it does not step on any important exchanges or background noises. There is no obvious age-related wear and tear to the track such as drop-outs, hissing, or popping. Warner Archive has put forth good work with this audio presentation. Optional English (SDH) subtitles are included for the feature film. Special Features A Look Back At Crossbow: A ten-minute archival featurette that takes a look at the real-life rocket program fictionalized in the feature film. Theatrical Trailer (2:36) Final Thoughts Operation Crossbow is a thrilling espionage movie that brings a personal touch to a very important wartime story. The movie takes some measures to feel authentic with Germans actually speaking in German with subtitles, and the movie establishes some heavy consequences to these heroic efforts. The performances are quite good all around, even if some of the tertiary characters could have been a bit more fully developed. This is definitely worth a watch for fans of wartime dramas. Warner Archive has released Blu-Ray featuring a stellar A/V presentation and a couple of special features. Recommended Operation Crossbow can be purchased directly through MovieZyng or various other online retailers. Note: Images presented in this review are not reflective of the image quality of the Blu-Ray. Disclaimer: Warner Archive has supplied a copy of this disc free of charge for review purposes. All opinions in this review are the honest reactions of the author.